Milad Zandi

TL;DR: The findings suggest that the current vaccine may be a promising vaccine to prevent SARS-CoV-2 infection and should be licensed to protect against infection with COVID-19.

TL;DR: In this paper , the authors describe the clinical and neurological complications of monkeypox infection, particularly encephalitis, as well as the laboratory diagnosis of these cases, and describe future efforts to prevent the spread of infectious disease surges can reduce mortality complications, the therapeutic burden on the health-care system, and prevent further spread.

TL;DR: In this paper, the potential role of cellular miRNAs in the SARS-CoV-2-host interplay as a therapeutic option in COVID-19 patients was reviewed.

TL;DR: In this article, the authors conducted a comprehensive systematic literature review of four online databases, including Web of Science, PubMed, Scopus and Embase, to systematically review the COVID-19 associated central nervous system manifestations, mental and neurological symptoms.

TL;DR: Wang et al. as mentioned in this paper reviewed respiratory microbiota dysbiosis among COVID-19 patients to encourage further studies on the field for assessment of SARS-CoV-2 and respiratory microbiota interaction.